New Genetic Links for Pancreatic Cancer - Tom Heston
Links shared publicly online about this topic.
- 1,426total visits
New Genetic Links for Pancreatic Cancer - Tom Heston
View full resource at tomheston.com
Tags: Pancreatic Disease, Genetic, Cancer, Pancreatic Cancer
Most Recently Shared on January 27, 2010 at 7:21 am By:
New Genetic Links for Pancreatic Cancer http://bit.ly/dDwpBx
Phase 2 study of HyperAcute Pancreas for the treatment of pancreatic cancer - MPR
empr.com — “NewLink Genetics announced additional data from its Phase 2 clinical trial of its HyperAcute Pancreas cancer immunotherapy for the treatment of resected pancreatic cancer.” View full resource at empr.com
Most Recently Shared on January 24, 2011 at 5:40 pm By:
MPR News: Phase 2 study of HyperAcute Pancreas for the treatment of pancreatic cancer: NewLink Genetics announce... http://bit.ly/hEYz5u
Phase 2 study of HyperAcute Pancreas for the treatment of pancreatic cancer - ONA
oncologynurseadvisor.com — “NewLink Genetics announced additional data from its Phase 2 clinical trial of its HyperAcute Pancreas cancer immunotherapy for the treatment of resected pancreatic cancer.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 24, 2011 at 4:55 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 2 study of HyperAcute Pancreas for the treatment of pancreatic cancer http://goo.gl/fb/MkFKm
NewLink Genetics reports positive data from Phase 2 trial of HyperAcute-Pancreas cancer immunotherapy
news-medical.net — “NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were presented in a poster session at the American Socie” View full resource at news-medical.net
Most Recently Shared on June 7, 2010 at 1:01 pm By:
Genetics News: NewLink Genetics reports positive data from Phase 2 trial of HyperAcute-Pancreas cancer immunoth... http://buzzup.com/zlv0_
NewLink Initiates Pivotal Phase 3 Clinical Trial Of HyperAcute(R)-Pancreas Immunotherapy For Resected Pancreatic Cancer
medicalnewstoday.com — “NewLink Genetics Corporation announced treatment of the first patient in a nationwide Phase 3 clinical trial of its HyperAcute®-Pancreas cancer immunotherapy for patients who have successfully” View full resource at medicalnewstoday.com
Most Recently Shared on May 28, 2010 at 2:07 pm By:
MNT Pancreatic Can Health News
NewLink Initiates Pivotal Phase 3 Clinical Trial Of HyperAcute(R)-Pancreas Immunotherapy For Resected Pancreatic Cancer http://mnt.to/3DdC
NewLink Genetics Receives Special Protocol Assessment Approval From FDA For Pivotal Phase 3 Trial In Pancreatic Cancer
medicalnewstoday.com — “NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 tria” View full resource at medicalnewstoday.com
Most Recently Shared on February 12, 2010 at 3:10 pm By:
MNT Pharma News Pharma and Health News
NewLink Genetics Receives Special Protocol Assessment Approval From FDA For Pivotal Phase 3 Trial In Pancreatic Cancer http://mnt.to/3xy5
NewLink Genetics receives FDA SPA approval for HyperAcute immunotherapy Phase 3 pancreatic cancer trial
news-medical.net — “NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need. The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of” View full resource at news-medical.net
Most Recently Shared on February 12, 2010 at 9:30 am By:
Genetics News: NewLink Genetics receives FDA SPA approval for HyperAcute immunotherapy Phase 3 pancreatic cancer... http://buzzup.com/o1h8
New Genetic Links for Pancreatic Cancer
tweetmeme.com — “Three newly discovered genetic variants may help explain pancreatic cancer risk and help prevent and treat new cases of the deadly disease.” View full resource at tweetmeme.com
Most Recently Shared on January 25, 2010 at 10:53 pm By:
Healthcare TweetMeme Health Social Media
New Genetic Links for Pancreatic Cancer http://retwt.me/1LIue (via @WebMD_News)
New Genetic Links for Pancreatic Cancer
webmd.com — “Three newly discovered genetic variants may help explain pancreatic cancer risk and help prevent and treat new cases of the deadly disease.” View full resource at webmd.com
Most Recently Shared on January 25, 2010 at 9:28 pm By:
New Genetic Links for Pancreatic Cancer: Three newly discovered genetic variants may help explain pancreatic cance... http://bit.ly/6iSEhb
No support for routine pancreatic cancer screening | Reuters
feeds.reuters.com — “NEW YORK (Reuters Health) - A new study fails to support routine pancreatic cancer screening for people at high genetic risk of the disease -- though, researchers say, at-risk individuals can still talk” View full resource at feeds.reuters.com
Most Recently Shared on October 14, 2009 at 3:03 pm By:
No support for routine pancreatic cancer screening http://link.reuters.com/sub83f
Advertisement
